Eli Lilly and Company: Clinical Trials & Research Profile

Biopharma Industry (Indianapolis, IN) · Primary Focus: Endocrinology, Obesity, and Metabolic

Clinical Trial MetricVerified Public Record
Organization TypeConsolidated Trial Sponsor
Institutional Sector & LocationBiopharma Industry (Indianapolis, IN)
Primary Therapeutic AreaEndocrinology, Obesity, and Metabolic
Active Phase II & III Studies146 active (77 recruiting now)
Total Tracked Studies (2018 to 2026)334 (262 with California sites)
Completed vs Early-Stopped Studies156 completed / 32 stopped (9.6% stop rate)
Median Closed Enrollment312 participants
FDA Drugs@FDA Original Approvals88 all-time (16 from 2018 to 2026)
Physical Hospital Site Disclosure100.0% named hospital slots

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Eli Lilly and Company across sibling Meru public-data platforms.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk